SCHEMBL4610330

SCHEMBL4610330

Cc1cc(-c2ccc(OCCN3C(=O)CCC3=O)cn2)ccc1F.Cc1cc(F)ccc1-c1ccc(OCCN2C(=O)CCC2=O)cn1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 9/20 0.36
GRIN1 Q05586 8/20 0.36
GRM5 P41594 3/20 0.36
PLA2G7 Q13093 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KCNH2 Q12809 1/20 0.34
SRC P12931 1/20 0.34
DAPK3 O43293 1/20 0.34
NTRK1 P04629 1/20 0.34
PIM1 P11309 1/20 0.34
FLT3 P36888 1/20 0.34
GSK3B P49841 1/20 0.34
ROCK1 Q13464 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
DGAT1 O75907 1/20 0.34
CXCR3 P49682 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4590739 0.91 GRM2 (0.38) GRIN2BGRIN1GRM5NPC1RAB9A
SCHEMBL4591010 0.91 PLA2G7 (0.41) GRIN2BGRIN1GRM5PLA2G7NPC1
SCHEMBL4591062 0.83 NPC1 (0.42) PLA2G7NPC1RAB9A
SCHEMBL4590069 0.83 NPC1 (0.42) GRM5PLA2G7NPC1RAB9A
SCHEMBL4590755 0.82 GRM2 (0.44) PLA2G7NPC1RAB9A
SCHEMBL4590528 0.81 NPC1 (0.46) PLA2G7NPC1RAB9A
SCHEMBL4590958 0.79 GRM2 (0.47) CXCR3
SCHEMBL4591441 0.78 NPC1 (0.40) PLA2G7NPC1RAB9A
SCHEMBL4590135 0.78 ESR1 (0.39) PLA2G7NPC1RAB9ACLK4
SCHEMBL4591304 0.77 KDM1A (0.37) PLA2G7NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899321-A1 HETEROARYL-SUBSTITUTED AMIDES COMPRISING A SATURATED LINKER GROUP, AND THEIR USE AS PHARMACEUTICALS Sanofi-Aventis (FR) 2008-03-19 EP disclosed
WO-2007000246-A1 HETEROARYL-SUBSTITUTED AMIDES COMPRISING A SATURATED LINKER GROUP, AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (DE) 2007-01-04 WO disclosed